{
    "clinical_study": {
        "@rank": "154669", 
        "acronym": "REPAIR", 
        "arm_group": [
            {
                "arm_group_label": "control group", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Control participants did not experience the procedure of transient upper-limb ischemia."
            }, 
            {
                "arm_group_label": "remote ischemic preconditioning (RIPC) group", 
                "arm_group_type": "Active Comparator", 
                "description": "Those randomized to RIPC group had a pneumatic medical tourniquet cuff (width , 5 cm ; length , 40 cm) placed around their upper arm at < 2 hours before the PCI procedure. The pneumatic medical cuff was inflated to a pressure of 200 mm Hg for 5 minutes , followed by 5 minutes of deflation to allow reperfusion. This procedure was repeated for 3 times."
            }
        ], 
        "brief_summary": {
            "textblock": "This single-center, randomized controlled trial is to investigate the impact of remote\n      ischemic preconditioning (RIPC) on the risk contrast-induced acute kidney injury and its\n      long-term impact on renal function for patients with diabetes undergoing percutaneous\n      coronary intervention."
        }, 
        "brief_title": "Remote Ischemic Preconditioning and Risk of Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary Stent Implantation", 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Acute Kidney Injury", 
        "condition_browse": {
            "mesh_term": [
                "Acute Kidney Injury", 
                "Wounds and Injuries"
            ]
        }, 
        "detailed_description": {
            "textblock": "Patients with diabetes undergoing elective percutaneous coronary intervention in Beijing\n      Anzhen Hospital were enrolled, and all the eligible participants were randomized to either\n      remote ischemic preconditioning (RIPC) group or control group. Those randomized to RIPC\n      group had a pneumatic medical tourniquet cuff (width , 5 cm ; length , 40 cm) placed around\n      their upper arm at < 2 hours before the PCI procedure. The pneumatic medical cuff was\n      inflated to a pressure of 200 mm Hg for 5 minutes , followed by 5 minutes of deflation to\n      allow reperfusion. This procedure was repeated for 3 times. Control participants did not\n      experience this procedure of transient upper-limb ischemia."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients  with diabetes undergoing percutaneous coronary intervention were included.\n\n        Exclusion Criteria:\n\n          1. emergency PCI,\n\n          2. baseline troponin value > 0.04 ng/mL,\n\n          3. nicorandil or glibenclamide use (preconditioning-mimetic and preconditioning-blocking\n             medication, respectively),\n\n          4. patient on dialysis,\n\n          5. patients who had some inability to cooperate with the trial,\n\n          6. those who could not give informed consent, and (7) second procedure of staged\n             elective PCI in this hospitalization."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "310", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 31, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01827891", 
            "org_study_id": "AZ-12"
        }, 
        "intervention": {
            "arm_group_label": "remote ischemic preconditioning (RIPC) group", 
            "description": "Those randomized to RIPC group had a pneumatic medical tourniquet cuff (width , 5 cm ; length , 40 cm) placed around their upper arm at < 2 hours before the PCI procedure. The pneumatic medical cuff was inflated to a pressure of 200 mm Hg for 5 minutes , followed by 5 minutes of deflation to allow reperfusion. This procedure was repeated for 3 times.", 
            "intervention_name": "remote ischemic preconditioning (RIPC)", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "acute kidney injury", 
            "percutaneous coronary intervention", 
            "remote ischemic preconditioning"
        ], 
        "lastchanged_date": "April 9, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Beijing", 
                    "country": "China", 
                    "zip": "100029"
                }, 
                "name": "Beijing Anzhen Hospital, Capital Medical University"
            }
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "Remote Ischemic Preconditioning and Risk of Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary Stent Implantation", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "China: National Natural Science Foundation", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The primary study endpoint was AKI, defined as an absolute rise in serum creatinine of \u2265 0.5 mg/dl or a relative increase of  \u2265 25% compared to baseline within 72 hours from PCI (the maximal measured concentration of serum creatinine during these 72 hours was used).", 
            "measure": "acute kidney injury", 
            "safety_issue": "Yes", 
            "time_frame": "72 hours after procedure"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01827891"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Beijing Anzhen Hospital", 
            "investigator_full_name": "Yujie Zhou", 
            "investigator_title": "professor of cardiology, Vice president of Beijing Anzhen Hospital", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Secondary endpoints were the relative reduction in estimated glomerular filtration rate (eGFR) as well as all cause mortality, myocardial infarction and stent thrombosis at 30-day and 180-day after procedure.", 
            "measure": "relative reduction in estimated glomerular filtration rate", 
            "safety_issue": "Yes", 
            "time_frame": "180 days after procedure"
        }, 
        "source": "Beijing Anzhen Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Beijing Anzhen Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}